Stay updated on VS-6766 and Everolimus Clinical Trial
Sign up to get notified when there's something new on the VS-6766 and Everolimus Clinical Trial page.

Latest updates to the VS-6766 and Everolimus Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a new Locations section with Surrey; removed the Surrey Locations block and the HHS Vulnerability Disclosure link as part of revision v3.3.3.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedAdded a note that PubMed publications are automatically filled from PubMed and may not be about the study, and updated the Revision to v3.3.2. Deleted the older wording stating that PubMed publications come from PubMed and are automatically created by ClinicalTrials.gov with Revision: v3.2.0.SummaryDifference0.1%

- Check48 days agoChange DetectedDeleted the government funding status notice from the study page, removing guidance about potential data delays and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check62 days agoChange DetectedThe page shows minor administrative updates (e.g., last update date and formatting) with no changes to the study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check91 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference2%

- Check98 days agoChange DetectedUpdated core content to replace references to ovarian cancer with multiple myeloma and bumped the revision from v3.0.2 to v3.1.0.SummaryDifference0.2%

Stay in the know with updates to VS-6766 and Everolimus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VS-6766 and Everolimus Clinical Trial page.